These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31398400)

  • 21. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REBACIN® as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection.
    Yang Y; Meng YL; Duan SM; Zhan SB; Guan RL; Yue TF; Kong LH; Zhou L; Deng LH; Huang C; Wang S; Wang GY; Wu DF; Zhang CF; Chen F
    Int J Cancer; 2019 Nov; 145(10):2712-2719. PubMed ID: 30989655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China.
    Yang Y; Ren J; Zhang Q
    J Med Virol; 2016 Feb; 88(2):345-50. PubMed ID: 26192265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV-16 targeted DNA vaccine expression: The role of purification.
    Almeida AM; Tomás J; Pereira P; Queiroz JA; Sousa F; Sousa Â
    Biotechnol Prog; 2018 Mar; 34(2):546-551. PubMed ID: 29314780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
    Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
    Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
    Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
    Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
    BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
    Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
    Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
    Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
    Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
    Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
    Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.
    Peng S; Tomson TT; Trimble C; He L; Hung CF; Wu TC
    Gene Ther; 2006 Feb; 13(3):257-65. PubMed ID: 16177818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism of carcinogenesis by human papillomavirus-16.
    Ishiji T
    J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.